Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 12399
Target5-hydroxytryptamine receptor 2A(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataIC50: 0.240nMAssay Description:The experiment was carried out at Cerep Contract Laboratories (Cat. ref. #471).Compound (I) was also tested in an in vivo set up demonstrating centra...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataIC50: 0.25nMAssay Description:The experiment was carried out at Cerep Contract Laboratories (Cat. ref. #471).Compound (I) was also tested in an in vivo set up demonstrating centra...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataIC50: 0.330nMAssay Description:The experiment was carried out at Cerep Contract Laboratories (Cat. ref. #471).Compound (I) was also tested in an in vivo set up demonstrating centra...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataIC50: 0.370nMAssay Description:The experiment was carried out at Cerep Contract Laboratories (Cat. ref. #471).Compound (I) was also tested in an in vivo set up demonstrating centra...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataIC50: 0.610nMAssay Description:The experiment was carried out at Cerep Contract Laboratories (Cat. ref. #471).Compound (I) was also tested in an in vivo set up demonstrating centra...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataIC50: 0.790nMAssay Description:The experiment was carried out at Cerep Contract Laboratories (Cat. ref. #471).Compound (I) was also tested in an in vivo set up demonstrating centra...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataIC50: 1.10nMAssay Description:The experiment was carried out at Cerep Contract Laboratories (Cat. ref. #471).Compound (I) was also tested in an in vivo set up demonstrating centra...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataIC50: 1.10nMAssay Description:The experiment was carried out at Cerep Contract Laboratories (Cat. ref. #471).Compound (I) was also tested in an in vivo set up demonstrating centra...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(1A) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  0.0500nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(1A) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  0.100nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(1A) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  0.100nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(1A) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  0.100nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(1A) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  0.140nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(1A) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  0.200nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(1A) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  0.220nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(1A) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  0.360nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(2) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  3.70nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(2) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  4.80nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(2) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  5.20nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(2) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  6.80nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(2) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  7nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(2) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  7.60nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(2) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  7.60nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetD(2) dopamine receptor(Human)
H. Lundbeck A/S

US Patent
LigandPNGBDBM50547397(Lu 31-130 | Zicronapine | LU-31-130 | US12116355, ...)
Affinity DataKi:  10nMAssay Description:The assay was performed as a SPA-based competition-binding in a 50 mM Tris pH 7.4 assay buffer containing 120 mM NaCl, 5 mM KCl, 4 mM MgCl2, 1.5 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent